| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 13,898 | 13,982 | 23:01 | |
| 13,816 | 13,988 | 22:00 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 15,000 | 124 | |||
| 14,852 | 280 | |||
| 14,500 | 45 | |||
| 14,138 | 420 | |||
| 13,988 | 420 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/via.htm [/URL] | ||||
| 420 | 13,818 | |||
| 420 | 13,816 | |||
| 3.530 | 13,730 | |||
| 420 | 13,670 | |||
| 3.530 | 13,356 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 8.320 | 0,155 | 1.289 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 14:41:30 | 14,138 | 55 |
| 11:47:58 | 14,132 | 2 |
| 09:04:38 | 14,108 | 5 |
| Tagesumsatz Xetra | -0,170 -1,20 % | 62 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Viatris reports positive Japanese phase 3 results for Nefecon in IgAN | 7 | Seeking Alpha | ||
| VIATRIS Aktie jetzt für 0€ handeln | |||||
| Mo | Viatris Reports Positive Results From Phase 3 IgAN Trial In Japan | 274 | AFX News | WASHINGTON (dpa-AFX) - Viatris Inc. (VTRS), a healthcare company, on Monday reported positive top-line results from a Phase 3 study evaluating VR-205 in Japanese adults with primary immunoglobulin... ► Artikel lesen | |
| Mo | Viatris Inc.: Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy | 937 | PR Newswire | VR-205 Met Primary Endpoint and Key Secondary Endpoints and Was Well Tolerated
VR-205 Efficacy and Safety Profile in Japanese Patients Was Consistent with the Profile... ► Artikel lesen | |
| 23.06. | VTRS vs. DHR: Which Stock Is the Better Value Option? | 18 | Zacks | ||
| 19.06. | How Is Viatris' Stock Performance Compared to Other Healthcare Stocks? | 16 | Barchart.com |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 14:15 | Novo Nordisk Aktie: Jefferies hebt Kursziel, bleibt vorsichtig | 4investors | Vor der Quartalsbilanz von Novo Nordisk am 5. August nehmen zwei Investmentbanken den dänischen Pharmakonzern unter die Lupe. Beide bleiben bei zurückhaltenden Einstufungen, setzen aber unterschiedliche... ► Artikel lesen | |
| 16:50 | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | ACCESS Newswire | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| 14:06 | LB Pharmaceuticals Inc: LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations | GlobeNewswire (Europe) | NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia... ► Artikel lesen | |
| 14:42 | Nxera Receives $10 Mln Milestone Payment From AbbVie | AFX News | TOKYO (dpa-AFX) - Nxera Pharma Co., Ltd. (SOLTF) on Tuesday said it received a $10 million milestone payment from AbbVie (ABBV) after achieving a fourth R&D milestone under their multi-target... ► Artikel lesen | |
| 18:10 | Cosmos Health Inc.: Cosmos Health Authorizes Up to $5 Million Share Repurchase Program | GlobeNewswire (Europe) | CHICAGO, June 30, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its... ► Artikel lesen |